Francis Chi
Director Ejecutivo en WALCOM GROUP LIMITED .
Perfil
Francis Chi is the founder of Obio Pharmaceutical Holdings Ltd.
He is currently the CEO, CFO & Executive Director at Walcom Group Ltd.
and the Director at Antiviral Technologies, Inc. Previously, he served as the Managing Director at Becoin Ltd.
and the Sales Manager at Listo Enterprises Co. Ltd.
Mr. Chi obtained his undergraduate degree from Seattle University in 1984.
Cargos activos de Francis Chi
| Empresas | Cargo | Inicio |
|---|---|---|
| WALCOM GROUP LIMITED | Director Ejecutivo | 01/01/2004 |
Antiviral Technologies, Inc.
 Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Director/Miembro de la Junta | 05/04/2010 |
Obio Pharmaceutical Holdings Ltd.
 Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | Fundador | - |
Antiguos cargos conocidos de Francis Chi.
| Empresas | Cargo | Fin |
|---|---|---|
| Becoin Ltd. | Corporate Officer/Principal | 01/01/1990 |
| Listo Enterprises Co. Ltd. | Ventas & Marketing | 01/01/1986 |
Formación de Francis Chi.
| Seattle University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Walcom Group Ltd.
 Walcom Group Ltd. Pharmaceuticals: GenericHealth Technology Walcom Group Ltd. is a holding company, which engages in the research, development, commercialization, production and marketing of animal feed additive products. Its products include Porcinin Plus, Porcimax, Eggronin Plus, and Aquanin Plus. It operates through the following geographical segments: Hong Kong, China, Philippines, Thailand, Taiwan, Other Asia-Pacific Countries, Europe and the United Kingdom, America and Canada, and Others. The company was founded in 2004 and is headquartered in Shanghai, China. | Health Technology |
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Finance |
Obio Pharmaceutical Holdings Ltd.
Obio Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Obio Pharmaceutical Holdings Ltd. is a holding There is no available country named vg company with interests in the pharmaceutical business. The private company was founded by Francis Chi. | Health Technology |
| Becoin Ltd. | |
| Listo Enterprises Co. Ltd. |
- Bolsa de valores
- Insiders
- Francis Chi
